Team:Queens Canada/Safety/FAQs
From 2011.igem.org
Line 24: | Line 24: | ||
design or accident?</a><span><br> | design or accident?</a><span><br> | ||
<span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#1c">c. Risks to environmental quality if released by design or accident?</a><span><br> | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#1c">c. Risks to environmental quality if released by design or accident?</a><span><br> | ||
- | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#1d">d. Risks to security through malicious misuse by individuals, groups or states?</a><span> | + | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#1d">d. Risks to security through malicious misuse by individuals, groups or states?</a><span><p> |
<regulartext><b> | <regulartext><b> | ||
Line 32: | Line 32: | ||
<span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#2a">a. Pathogenicity, infectivity, or toxicity? </a><span><br> </regulartext> | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#2a">a. Pathogenicity, infectivity, or toxicity? </a><span><br> </regulartext> | ||
<span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#2b">b. Threats to environmental quality?</a><span><br> | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#2b">b. Threats to environmental quality?</a><span><br> | ||
- | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#2c">c. Security concerns?</a><span>< | + | <span class="classredt2"><a href="https://2011.igem.org/Team:Queens_Canada/Safety/FAQs#2c">c. Security concerns?</a><span><p> |
Revision as of 04:52, 23 September 2011
a. Risks to the safety and health of team members or others in the lab?
b. Risks to the safety and health of the general public if released by
design or accident?
c. Risks to environmental quality if released by design or accident?
d. Risks to security through malicious misuse by individuals, groups or states?
c. Security concerns?
a. Does your institution have its own bio-safety rules and if so what are they?
b. Does your institution have an Institutional Biosafety Committee or
equivalent group? If yes, have you discussed your project with them?
c. Will / did you receive any biosafety and/or lab training before
beginning your project? If so, describe this training.
d. Does your country have national biosafety regulations or
guidelines?